1 |
周结学, 刘东, 蒙善东, 等. 体外光化学疗法对大鼠肾移植抗排斥反应的研究[J]. 实用医学杂志, 2023, 39(8): 944-947.
|
2 |
MONTANO-LOZA A J, RODRÍGUEZ-PERÁLVAREZ M L, PAGEAUX G P, et al. Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation [J]. J Hepato, 2023, 78(6): 1199-1215.
|
3 |
FAHRNER R, DONDORF F, ARDELT M, et al. Role of NK, NKT cells and macrophages in liver transplantation[J]. World J Gastroenterol, 2016, 22(27): 6135-6144.
|
4 |
JIA J, TIAN X, JIANG J, et al. Structural shifts in the intestinal microbiota of rats treated with cyclosporine A after orthotropic liver transplantation [J]. Front Med, 2019, 13(4): 451-460.
|
5 |
MENG Q, WU W, ZHANG W, et al. IL-18BP improves early graft function and survival in lewis-brown norway rat orthotopic liver transplantation model[J]. Biomolecules, 2022, 12(12): 1801.
|
6 |
MO J, CHEN Y, CHENG Y, et al. miR-199a-3p may be an early warning marker for acute rejection after liver transplantation in rats [J]. Cytokine, 2021, 148:155689.
|
7 |
张继翔, 闫宏宪, 轩娟娟, 等. 门脉优先反向吻合快速建立肝移植大鼠模型[J]. 中国组织工程研究, 2022, 26(17): 2696-2701.
|
8 |
ZHOU M, HUI J, GAO L, et al. Extracellular vesicles from bone marrow mesenchymal stem cells alleviate acute rejection injury after liver transplantation by carrying miR-22-3p and inducing M2 polarization of Kupffer cells[J]. J Gene Med, 2023, e3497.
|
9 |
OLDANI G, PELOSO A, VIJGEN S, et al. Chimeric liver transplantation reveals interspecific graft remodelling[J]. J Hepatol, 2018, 69(5): 1025-1036.
|
10 |
SONG C, WANG G, MA X, et al. The effect of miR-155-5p on M1 polarization of Kupffer cells and immune response during liver transplantation through regulating the expression of KDM5D[J]. Mol Immunol, 2023, 155: 17-26.
|
11 |
MISUMI M, YAMAGUCHI Y, MORI K, et al. In situ macrophage distribution in the hepatic allograft associated with rejection in the rat[J]. J Surg Res, 1993, 55(2): 115-121.
|
12 |
GOMAA A I, EHSAN N A, ELREFAEI A A, et al. The role of monocyte/macrophage and CXCR3 in differentiation between recurrent hepatitis C and acute cellular rejection postliver transplantation[J]. J Immunol Res, 2018, 2018: 2726939.
|
13 |
SAWADA T, SHIMIZU A, KUBOTA K, et al. Lobular damage caused by cellular and humoral immunity in liver allograft rejection[J]. Clin Transplant, 2005, 19(1): 110-114.
|
14 |
ABDOU A G, ASAAD N Y, EHSAN N, et al. The diagnostic impact of C4d, CD68, and NF-κB expression in the differentiation between recurrent hepatitis C and acute cellular rejection after liver transplantation[J]. Appl Immunohistochem Mol Morphol, 2016, 24(9): 639-647.
|
15 |
李泽桦, 曾宇宏, 冯丽芸, 等. 氧化三甲胺促进M1型巨噬细胞极化加剧心肌梗死后心室重构[J]. 实用医学杂志, 2022, 38(20): 2531-2537,2544.
|
16 |
CAO Z R, ZHENG W X, JIANG Y X, et al. miR-449a ameliorates acute rejection after liver transplantation via targeting procollagen-lysine1, 2-oxoglutarate5 -dioxygenase 1 in macrophages[J]. Am J Transplant, 2023, 23(3): 336-352.
|
17 |
YANG P, ZHANG X, LIN Z, et al. Adoptive transfer of polarized M2c macrophages ameliorates acute rejection in rat liver transplantation[J]. Am J Transl Res, 2020, 12(6): 2614-2626.
|
18 |
ANGERMÜLLER S, STEINMETZ I, WEBER T, et al. Significant increase of Kuppfer cells associated with loss of Na+,K+-ATPase activity in rat hepatic allograft rejection[J]. Transplantation, 1997, 63(11):1562-1570.
|
19 |
LI X, LI S, WU B, et al. Landscape of Immune Cells Heterogeneity in Liver Transplantation by Single-Cell RNA Sequencing Analysis[J]. Front Immunol, 2022, 13: 890019.
|
20 |
SU H, NA N, ZHANG X, et al. The biological function and significance of CD74 in immune diseases[J]. Inflamm Res, 2017, 66(3): 209-216.
|
21 |
XIAO N, LI K, ZHU X, et al. CD74+ macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinoma[J]. Cancer Immunol Immunother, 2022, 71(1): 57-69.
|
22 |
YANG Z, HAN X, WANG K, et al. Combined with multiplex and network analysis to reveal the key genes and mechanisms of nonalcoholic fatty liver disease[J]. Int Immunopharmacol, 2023, 123: 110708.
|
23 |
MARCOVECCHIO P M, THOMAS G, SALEK-ARDAKANI S. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer[J]. J Immunother Cancer, 2021, 9(2): e002045.
|
24 |
MEHANNA R G, MOHIEDEEN K, KASSEM M, et al. Assessment of serum CXCL9 and pentraxin 3 as novel markers for hepatocellular carcinoma in cirrhotic hepatitis C patients[J]. Clin Exp Hepatol, 2023, 9(1):14-20.
|
25 |
ASAOKA T, MARUBASHI S, KOBAYASHI S, et al. Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation[J]. J Surg Res, 2012, 178(2): 1003-1014.
|
26 |
DENG J F, GENG L, QIAN Y G, et al. The role of toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation[J]. Transplant Proc, 2007, 39(10): 3222-3224
|